The treatment of cerebral cavernous malformation-related hemorrhage using β-blocker medication

被引:2
|
作者
Zhao, Lei [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Xian, Shaanxi, Peoples R China
关键词
PROPRANOLOL TREATMENT; HEMANGIOMAS;
D O I
10.3171/2018.11.JNS183257
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:2090 / 2091
页数:2
相关论文
共 50 条
  • [21] Hemorrhage owing to cerebral cavernous malformation: imaging, clinical, and histopathological considerations
    Kurihara, Noriko
    Suzuki, Hiroyoshi
    Kato, Yumiko
    Rikimaru, Hiroya
    Sato, Akihiro
    Uenohara, Hiroshi
    JAPANESE JOURNAL OF RADIOLOGY, 2020, 38 (07) : 613 - 621
  • [22] Bleeding risk of cerebral cavernous malformations in patients on β-blocker medication: a cohort study
    Goldberg, Johannes
    Jaeggi, Christian
    Schoeni, Daniel
    Mordasini, Pasquale
    Raabe, Andreas
    Bervini, David
    JOURNAL OF NEUROSURGERY, 2019, 130 (06) : 1931 - 1936
  • [23] Medication intake and hemorrhage risk in patients with familial cerebral cavernous malformations
    Santos, Alejandro N.
    Rauschenbach, Laurel
    Saban, Dino
    Chen, Bixia
    Lenkeit, Annika
    Gull, Hanah Hadice
    Riess, Christoph
    Deuschl, Cornelius
    Schmidt, Boerge
    Jabbarli, Ramazan
    Wrede, Karsten H.
    Zhu, Yuan
    Frank, Benedikt
    Sure, Ulrich
    Dammann, Philipp
    JOURNAL OF NEUROSURGERY, 2022, 137 (04) : 1088 - 1094
  • [24] Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation
    Weinsheimer, Shantel
    Nelson, Jeffrey
    Abla, Adib A.
    Ko, Nerissa U.
    Tsang, Cynthia
    Okoye, Obiora
    Zabramski, Joseph M.
    Akers, Amy
    Zafar, Atif
    Mabray, Marc C.
    Hart, Blaine L.
    Morrison, Leslie
    McCulloch, Charles E.
    Kim, Helen
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (03):
  • [25] CENTRAL SLEEP APNEA AS A RESULT OF CEREBRAL CAVERNOUS MALFORMATION HEMORRHAGE IN THE PEDIATRIC POPULATION
    Bowling, Joshua
    Hassan, Fauziya
    SLEEP, 2022, 45 : A348 - A348
  • [26] Strategy for Identifying Repurposed Drugs for the Treatment of Cerebral Cavernous Malformation
    Gibson, Christopher C.
    Zhu, Weiquan
    Davis, Chadwick T.
    Bowman-Kirigin, Jay A.
    Chan, Aubrey C.
    Ling, Jing
    Walker, Ashley E.
    Goitre, Luca
    Delle Monache, Simona
    Retta, Saverio Francesco
    Shiu, Yan-Ting E.
    Grossmann, Allie H.
    Thomas, Kirk R.
    Donato, Anthony J.
    Lesniewski, Lisa A.
    Whitehead, Kevin J.
    Li, Dean Y.
    CIRCULATION, 2015, 131 (03) : 289 - +
  • [27] Microsurgical Treatment and Outcome of Pediatric Supratentorial Cerebral Cavernous Malformation
    Noh, Jung-Hoon
    Cho, Kyung Rae
    Yeon, Je Young
    Seol, Ho Jun
    Shin, Hyung Jin
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2014, 56 (03) : 237 - 242
  • [28] Cerebral hemorrhage from an incidental cavernous malformation occurring at the progressive stage of immunoglobulin G4-related disease
    Ayabe, Junnichi
    Noda, Naoyuki
    Tsuchiya, Yuusuke
    Toginn, Souta
    Tanaka, Yoshihide
    Mishima, Hiroyuki
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2018, 14 : 76 - 79
  • [29] Association between β blocker or statin drug use and hemorrhage from cerebral cavernous malformations
    Zuurbier, S.
    Hickman, C.
    Rinkel, L.
    Leyrer, R.
    Sure, U.
    Salman, R. Al-Shahi
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 50 - 50
  • [30] Clinical characteristics and risk factors of cerebral cavernous malformation related epilepsy
    Zhang, Peng
    Cheng, Jing
    Shi, Chenjun
    Dong, Jun
    Li, Rong
    Zhang, Hui
    Chen, Yangmei
    EPILEPSIA, 2021, 62 : 53 - 53